About the Company
NantKwest (NASDAQ: NK) is an innovative, clinical-stage, immunotherapy company focused on harnessing the power of the innate immune system to treat cancer and infectious diseases. NantKwest is the leading producer of clinical dose forms of off-the-shelf natural killer (NK) cell therapies. The activated NK cell platform is designed to destroy cancer and virally-infected cells. The safety of these optimized, activated NK cells-as well as their activity against a broad range of cancers-has been tested in phase I clinical trials in Canada and Europe, as well as in multiple phase I and II clinical trials in the United States. By leveraging an integrated and extensive genomics and transcriptomics discovery and development engine, together with a pipeline of multiple, clinical-stage, immuno-oncology programs, NantKwest's goal is to transform medicine by bringing novel NK cell-based therapies to routine clinical care. NantKwest is a member of the NantWorks ecosystem of companies.
CEO
Exchange
NASDAQ/NGS (GLOBAL SELECT MARKET)
Website
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $NK News
ImmunityBio Drug Gets FDA Nod
After years of effort, delays and hundreds of millions of dollars of billionaire Patrick Soon-Shiong’s own money, last week ...
how did patrick soon-shiong become so rich?
It was Huang (*) that he was named after. The pharmaceutical company NantKwest and the biotech company NantHealth were both made public in 2015 and 2016 respectively. is the founder of NantWorks, a ...
Fighting a war on two fronts: ImmunityBio targets cancer and COVID-19
ImmunityBio, Inc. is a privately held immunotherapy company ... These vaccines are currently undergoing clinical evaluation by NantKwest, a clinical-stage immunotherapy company harnessing the ...
Netlist, Inc. (NLST)
Netlist, Inc. (PNK:NLST) Q1 2024 Earnings Call Transcript April 25, 2024 Netlist, Inc. misses on earnings expectations. Reported EPS is $-0.07 EPS, expectations were $-0.05. NLST isn’t one of ...
VMware, Inc.
Scale Computing CEO Jeff Ready called out Broadcom for “profit harvesting” a hospital charity during mainstage at his recent partner show, a story so extraordinary, CRN tracked down the ...
About Inc.com | Everything You Need to Know to Grow and Start Your Business
Inc. is the voice of the American entrepreneur. We inspire, inform, and document the most fascinating people in business: the risk-takers, the innovators, and the ultra-driven go-getters that ...
Inc. 5000 Conference
She spoke at the 2023 Inc. 5000 Conference about the difference between marketing and advertising. At the Inc. 5000 Conference, Howroyd, the first Black woman to build and own a billion-dollar ...
TPX Tempur Sealy International, Inc.
Tempur Sealy International, Inc., together with its subsidiaries, designs, manufactures, distributes, and retails bedding products in the United States and internationally. It provides mattresses ...
Tanger Inc. Common Stock (SKT)
The Dividend History page provides a single page to review all of the aggregated Dividend payment information. Visit our Dividend Calendar: Our partner, Quotemedia, provides the upcoming ex ...
The Rise of China, Inc.
China, Inc.' enjoys the agility of a firm and the vast resources of a state. Meanwhile, foreign firms competing with Chinese firms can find themselves matched against the mighty Chinese state. The ...
Apple Inc. (AAPL) Interactive Stock Chart - Yahoo Finance
With the peak of first quarter earnings season in the rearview, stocks got back to their winning ways last week ahead of a slower calendar for corporate and economic news. Google has a lot at stake as ...
Loading the latest forecasts...